NewYork-Presbyterian has adopted Signal 1’s AI Management System (AIMS) to govern and monitor artificial intelligence tools deployed across the New York City-based health system.
The platform will oversee AI technologies ranging from cancer and structural heart disease detection tools to applications supporting discharge planning and clinical documentation, according to an Aug. 3 news release. NewYork-Presbyterian worked closely with Signal 1 to design the platform and establish best practices for responsible AI management in healthcare.
AIMS builds on NewYork-Presbyterian’s existing governance framework, which the health system uses to evaluate AI for safety, performance and accountability. The platform adds a centralized system for managing predictive AI, generative AI and emerging AI agents, with standardized risk assessment, continuous monitoring, bias detection and audit capabilities.
The move reflects a broader shift among health systems, which are increasingly managing AI as a single portfolio rather than evaluating each new tool on its own.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.